|
1 hit(s) found in 0.07 seconds Search term: IJKVHSBPTUYDLN-UHFFFAOYAA Found by InChIKey (full match)
Please
login
to be able to add spectra, identifiers, links and publications.
thumb|right|Annual mean sea surface silicic acid for the World Ocean Atlas [http://www.nodc.noaa.gov/OC5/WOA05/ 2005">Ocean. Data from the World Ocean Atlas [http://www.nodc.noaa.gov/OC5/WOA05/ 2005.]]
Silicic acid is a general name for a family of chemical compounds of the element silicon, hydrogen, and oxygen, with the general formula n. Some simple silicic acids have been identified in very dilute aqueous solution, such as metasilicic acid (H 2SiO 3), orthosilicic acid (H 4SiO 4, pK a1=9.84, pK a2=13.2 at 25°C), disilicic acid (H 2Si 2O 5), and pyrosilicic acid (H 6Si 2O 7); however in the solid state these probably condense to form polymeric silicic acids of complex structure.
Silicic acids may be formed by acidification of silicate salts (such as sodium silicate) in aqueous solution. When heated they lose water to form silica gel, an active form of silicon dioxide.
In the oceans, silicon exists primarily as orthosilicic acid (H 4SiO 4), and its biogeochemical cycle is regulated by the group of algae known as the diatoms. These algae polymerise the silicic acid to so-called biogenic silica, used to construct their cell walls (called frustules).
Continuing research of the correlation of aluminium and Alzheimer's disease has in the last few years included the use of silicic acid in beverages, due to its abilities to both reduce aluminium uptake in the digestive system as well as cause renal excretion of aluminium.
Orthosilicic acid is the form predominantly absorbed by humans and is found in numerous tissues including bone, tendons, aorta, liver and kidney. Compelling data suggest that silica is essential for health although no RDI has been established. However, deficiency induces deformities in skull and peripheral bones, poorly formed joints, reduced contents of cartilage, collagen, and disruption of mineral balance in the femur and vertebrae.
Study has shown that physiological concentration of orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro.
Choline-stabilized orthosilicic acid is bioavailable nutritional supplement. It has been shown to prevent the loss of hair tensile strength, have positive effect on skin surface and skin mechanical properties, and on brittleness of hair and nails, abate brittle nail syndrome, partially prevent femoral bone loss in the aged ovariectomized rat model, increase collagen concentration in calves
, and have potential beneficial effect on bone collagen formation in osteopenic females.
Read more... or Edit at Wikipedia...
Validated by Experts, Validated by Users, Non-Validated, Removed by Users,
Redirected by Users, Redirect Approved by Experts
14807-96-6
[RN]
215-683-2
[EINECS/ELINCS]
231-716-3
[EINECS/ELINCS]
238-877-9
[EINECS/ELINCS]
Oxosilanediol
silicic acid (H_2_SiO_3_)
10193-36-9
[RN]
12673-75-5
[RN]
1343-98-2
[RN]
158296-67-4
[RN]
More...
20761-29-9
[RN]
231-545-4
[EINECS/ELINCS]
62647-19-2
[RN]
68373-08-0
[RN]
7699-41-4
[RN]
84141-05-9
[RN]
9063-16-5
[RN]
98530-20-2
[RN]
Acidum silicicum
Bio-Sil
Cubosic
EINECS 215-683-2
EINECS 231-716-3
H-Ilerit
Hydrosilisic acid
K 320DS
K 60 (silicate)
Kieselsaure
[German]
Kieselsaure [German]
metasilicic acid
Mikronisil
Neoxyl ET
Polyorthosilicic acid
Polysilicic acid
Precipitated, and gel [Silica, amorphous]
Silica acid
silica gel
silicic acid
Silicic acid (H2SiO3)
Silicic acid (polyortho)
Silicic acid hydrate
Silicon hydroxide
Silton TF 06
Sipernat 17
Sipernat 50
Sipernat 50S
Sipernat D 10
Sipernat S
Talc (Mg3H2(SiO3)4)
Vulcasil S/GR
Zeosil 45
Less...
Validated by Experts, Validated by Users, Non-Validated, Removed by Users,
Redirected by Users, Redirect Approved by Experts
|
ACD/LogP: |
|
# of Rule of 5 Violations: |
|
|
ACD/LogD (pH 5.5): |
|
ACD/LogD (pH 7.4): |
|
|
ACD/BCF (pH 5.5): |
|
ACD/BCF (pH 7.4): |
|
|
ACD/KOC (pH 5.5): |
|
ACD/KOC (pH 7.4): |
|
|
#H bond acceptors: |
3
|
#H bond donors: |
2
|
|
#Freely Rotating Bonds: |
0
|
Polar Surface Area: |
35.53
Å2
|
|
Index of Refraction: |
|
Molar Refractivity: |
cm3
|
|
Molar Volume: |
cm3
|
Polarizability: |
10-24cm3
|
|
Surface Tension: |
dyne/cm
|
Density: |
g/cm3
|
|
Flash Point: |
°C
|
Enthalpy of Vaporization: |
kJ/mol
|
|
Boiling Point: |
°C at 760 mmHg
|
Vapour Pressure: |
mmHg at 25°C
|
Log Octanol-Water Partition Coef (SRC):
Log Kow (KOWWIN v1.67 estimate) = -1.50
Boiling Pt, Melting Pt, Vapor Pressure Estimations (MPBPWIN v1.42):
Boiling Pt (deg C): 549.66 (Adapted Stein & Brown method)
Melting Pt (deg C): 219.74 (Mean or Weighted MP)
VP(mm Hg,25 deg C): 1.29E-014 (Modified Grain method)
Subcooled liquid VP: 1.55E-012 mm Hg (25 deg C, Mod-Grain method)
Water Solubility Estimate from Log Kow (WSKOW v1.41):
Water Solubility at 25 deg C (mg/L): 1e+006
log Kow used: -1.50 (estimated)
no-melting pt equation used
Water Sol Estimate from Fragments:
Wat Sol (v1.01 est) = 1e+006 mg/L
ECOSAR Class Program (ECOSAR v0.99h):
Class(es) found:
Neutral Organics
Henrys Law Constant (25 deg C) [HENRYWIN v3.10]:
Bond Method : Incomplete
Group Method: Incomplete
Henrys LC [VP/WSol estimate using EPI values]: 1.326E-021 atm-m3/mole
Log Octanol-Air Partition Coefficient (25 deg C) [KOAWIN v1.10]:
Can Not Estimate (can not calculate HenryLC)
Probability of Rapid Biodegradation (BIOWIN v4.10):
Biowin1 (Linear Model) : 0.7104
Biowin2 (Non-Linear Model) : 0.8699
Expert Survey Biodegradation Results:
Biowin3 (Ultimate Survey Model): 3.0266 (weeks )
Biowin4 (Primary Survey Model) : 3.7351 (days-weeks )
MITI Biodegradation Probability:
Biowin5 (MITI Linear Model) : 0.4798
Biowin6 (MITI Non-Linear Model): 0.5673
Anaerobic Biodegradation Probability:
Biowin7 (Anaerobic Linear Model): 0.8361
Ready Biodegradability Prediction: NO
Hydrocarbon Biodegradation (BioHCwin v1.01):
Structure incompatible with current estimation method!
Sorption to aerosols (25 Dec C)[AEROWIN v1.00]:
Vapor pressure (liquid/subcooled): 2.07E-010 Pa (1.55E-012 mm Hg)
Log Koa (): not available
Kp (particle/gas partition coef. (m3/ug)):
Mackay model : 1.45E+004
Octanol/air (Koa) model: not available
Fraction sorbed to airborne particulates (phi):
Junge-Pankow model : 1
Mackay model : 1
Octanol/air (Koa) model: not available
Atmospheric Oxidation (25 deg C) [AopWin v1.92]:
Hydroxyl Radicals Reaction:
OVERALL OH Rate Constant = 6.9000 E-12 cm3/molecule-sec
Half-Life = 1.550 Days (12-hr day; 1.5E6 OH/cm3)
Half-Life = 18.602 Hrs
Ozone Reaction:
No Ozone Reaction Estimation
Fraction sorbed to airborne particulates (phi): 1 (Junge,Mackay)
Note: the sorbed fraction may be resistant to atmospheric oxidation
Soil Adsorption Coefficient (PCKOCWIN v1.66):
Koc : 35.04
Log Koc: 1.545
Aqueous Base/Acid-Catalyzed Hydrolysis (25 deg C) [HYDROWIN v1.67]:
Rate constants can NOT be estimated for this structure!
Bioaccumulation Estimates from Log Kow (BCFWIN v2.17):
Log BCF from regression-based method = 0.500 (BCF = 3.162)
log Kow used: -1.50 (estimated)
Volatilization from Water:
Henry LC: 1.33E-021 atm-m3/mole (calculated from VP/WS)
Half-Life from Model River: 3.903E+017 hours (1.626E+016 days)
Half-Life from Model Lake : 4.258E+018 hours (1.774E+017 days)
Removal In Wastewater Treatment:
Total removal: 1.85 percent
Total biodegradation: 0.09 percent
Total sludge adsorption: 1.75 percent
Total to Air: 0.00 percent
(using 10000 hr Bio P,A,S)
Level III Fugacity Model:
Mass Amount Half-Life Emissions
(percent) (hr) (kg/hr)
Air 2.58e-008 37.2 1000
Water 39 360 1000
Soil 60.9 720 1000
Sediment 0.0713 3.24e+003 0
Persistence Time: 579 hr
Descriptors:
0, 0, 0, 2, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 2, 0, 0, 0, 0
| Category | Target | PDB Code | LASSO Score |
| Other Enzymes | ALR2, aldose reductase | 1ah3 | 1.00 |
| Folate Enzymes | GART, glycinamide ribonucleotide transformylase | 1c2t | 0.99 |
| Folate Enzymes | DHFR, dihydrofolate reductase | 3dfr | 0.96 |
| Other Enzymes | PNP, purine nucleoside phosphorylase | 1b8o | 0.34 |
| Kinases | CDK2, cyclindependent kinase 2 | 1ckp | 0.26 |
| Metalloenzymes | ACE, angiotensin-converting enzyme | 1o86 | 0.20 |
| Other Enzymes | COX-1, cyclooxygenase-1 | 1p4g | 0.19 |
| Nuclear Hormone Receptors | PPARg, peroxisome proliferator activated receptor | 1fm9 | 0.11 |
| Other Enzymes | NA, neuraminidase | 1a4g | 0.05 |
| Other Enzymes | AmpC, AmpC beta-lactamase | 1xgj | 0.05 |
| Kinases | SRC, tyrosine kinase SRC | 2src | 0.02 |
| Kinases | HSP90, human heat shock protein 90 | 1uy6 | 0.02 |
| Other Enzymes | SAHH, S-adenosyl-homocysteine hydrolase | 1a7a | 0.02 |
| Other Enzymes | HMGR, hydroxymethylglutaryl-CoA reductase | 1hw8 | 0.01 |
| Kinases | FGFr1, fibroblast growth factor receptor kinase | 1agw | 0.01 |
| Metalloenzymes | ADA, adenosine deaminase | 1stw | 0.01 |
| Kinases | VEGFr2, vascular endothelial growth factor receptor | 1vr2 | 0.00 |
| Nuclear Hormone Receptors | ER, estrogen receptor; agonist | 1l2i | 0.00 |
| Other Enzymes | GPB, glycogen phosphorylase | 1a8i | 0.00 |
| Nuclear Hormone Receptors | PR, progesterone receptor | 1sr7 | 0.00 |
| Other Enzymes | HIVPR, HIV protease | 1hpx | 0.00 |
| Other Enzymes | HIVRT, HIV reverse transcriptase | 1rt1 | 0.00 |
| Nuclear Hormone Receptors | MR, mineralocorticoid receptor | 2aa2 | 0.00 |
| Kinases | TK, thymidine kinase | 1kim | 0.00 |
| Kinases | EGFr, epidermal growth factor receptor | 1m17 | 0.00 |
| Nuclear Hormone Receptors | AR, androgen receptor | 1xq2 | 0.00 |
| Nuclear Hormone Receptors | RXRa, retinoic X receptor R | 1mvc | 0.00 |
| Kinases | PDGFrb, platelet derived growth factor receptor kinase | N/A | 0.00 |
| Other Enzymes | PARP, poly(ADP-ribose) polymerase | 1efy | 0.00 |
| Metalloenzymes | COMT, catechol O-methyltransferase | 1h1d | 0.00 |
| Other Enzymes | COX-2, cyclooxygenase-2 | 1cx2 | 0.00 |
| Other Enzymes | AChE, acetylcholinesterase | 1eve | 0.00 |
| Kinases | P38 MAP, P38 mitogen activated protein | 1kv2 | 0.00 |
| Serine Proteases | FXa, factor Xa | 1f0r | 0.00 |
| Serine Proteases | Thrombin | 1ba8 | 0.00 |
|
|